Recent Finacing
Recent Raise
AOA Dx develops GlycoLocate™-based liquid‑biopsy assay AKRIVIS GD to detect ovarian cancer via glycolipid/ganglioside biomarkers and is conducting clinical trials in Boston, New York and London.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at AOA.
